ADAMS; Camellia W.
Patent Applications and Registrations
Patent applications and USPTO patent grants for ADAMS; Camellia W..The latest application filed is for "immunoglobulin variants and uses thereof".
Company Profile
1.29.38
- ADAMS; Camellia W. - Mountain View CA
- Adams; Camellia W. - San Jose CA US
- Adams; Camellia W - Mountain View CA
- Adams; Camellia W. - Mountainview CA
Patent Activity
| Patent | Date |
|---|---|
| Immunoglobulin Variants And Uses Thereof App 20220002430 - ADAMS; Camellia W. ; et al. | 2022-01-06 |
| Immunoglobulin Variants And Uses Thereof App 20190071511 - ADAMS; Camellia W. ; et al. | 2019-03-07 |
| Immunoglobulin Variants And Uses Thereof App 20170158773 - ADAMS; Camellia W. ; et al. | 2017-06-08 |
| Immunoglobulin Variants And Uses Thereof App 20140154242 - ADAMS; Camellia W. ; et al. | 2014-06-05 |
| Antibodies to lymphotoxin-alpha Grant 8,642,740 - Adams , et al. February 4, 2 | 2014-02-04 |
| Immunoglobulin variants and uses thereof Grant 8,562,992 - Adams , et al. October 22, 2 | 2013-10-22 |
| Antibodies to lymphotoxin-.alpha. Grant 8,541,552 - Adams , et al. September 24, 2 | 2013-09-24 |
| Method of inducing apoptosis using anti-DR5 antibodies Grant 8,409,570 - Adams , et al. April 2, 2 | 2013-04-02 |
| Antibodies To Lymphotoxin-alpha App 20130011412 - Adams; Camellia W. ; et al. | 2013-01-10 |
| Antibodies to lymphotoxin-.alpha. Grant 8,216,807 - Adams , et al. July 10, 2 | 2012-07-10 |
| Dr5 Antibodies And Uses Thereof App 20120087922 - Adams; Camellia W. ; et al. | 2012-04-12 |
| Antibodies to Apo-2 receptor polypeptides Grant 8,092,799 - Adams , et al. January 10, 2 | 2012-01-10 |
| Nucleic acid encoding DR5 antibodies and uses thereof Grant 8,030,023 - Adams , et al. October 4, 2 | 2011-10-04 |
| DR5 antibodies and articles of manufacture containing same Grant 8,029,783 - Adams , et al. October 4, 2 | 2011-10-04 |
| Humanized anti-TGF-beta antibodies Grant 8,012,482 - Adams , et al. September 6, 2 | 2011-09-06 |
| Antibodies To Lymphotoxin-alpha App 20110208673 - Adams; Camellia W. ; et al. | 2011-08-25 |
| Antibodies To Lymphotoxin-alpha App 20110150865 - Adams; Camellia W. ; et al. | 2011-06-23 |
| Humanized Anti-erbb2 Antibodies And Treatment With Anti-erbb2 Antibodies App 20110129464 - ADAMS; CAMELLIA W. ; et al. | 2011-06-02 |
| Antibodies to lymphotoxin-alpha Grant 7,923,011 - Adams , et al. April 12, 2 | 2011-04-12 |
| Antibodies To Apo-2 Receptor Polypeptides App 20110008354 - ADAMS; CAMELLIA W. ; et al. | 2011-01-13 |
| Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies Grant 7,862,817 - Adams , et al. January 4, 2 | 2011-01-04 |
| Apo-2 receptor agonist antibodies Grant 7,807,153 - Adams , et al. October 5, 2 | 2010-10-05 |
| Immunoglobulin variants and uses thereof Grant 7,799,900 - Adams , et al. September 21, 2 | 2010-09-21 |
| Humanized Anti-tgf-beta Antibodies App 20090285810 - Adams; Camellia W. ; et al. | 2009-11-19 |
| Antibodies To Lymphotoxin-alpha App 20090285830 - Adams; Camellia W. ; et al. | 2009-11-19 |
| Treatment of cancer using anti-Apo-2 antibodies Grant 7,595,046 - Adams , et al. September 29, 2 | 2009-09-29 |
| Immunoglobulin Variants And Uses Thereof App 20090155257 - ADAMS; CAMELLIA W. ; et al. | 2009-06-18 |
| Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies Grant 7,537,931 - Adams , et al. May 26, 2 | 2009-05-26 |
| Humanized anti-TGF-beta antibodies Grant 7,527,791 - Adams , et al. May 5, 2 | 2009-05-05 |
| Treatment with anti-ErbB2 antibody combinations Grant 7,501,122 - Adams , et al. March 10, 2 | 2009-03-10 |
| Treatment with anti-ErbB2 antibodies and anti-hormonal compounds Grant 7,498,030 - Adams , et al. March 3, 2 | 2009-03-03 |
| Treatment with anti-ErbB2 antibodies and chemotherapeutic agents Grant 7,485,302 - Adams , et al. February 3, 2 | 2009-02-03 |
| Methods of treating coagulapathic or thrombotic disorders Grant 7,354,585 - Adams , et al. April 8, 2 | 2008-04-08 |
| Inducing apoptosis using anti-Apo-2 antibodies Grant 7,314,619 - Adams , et al. January 1, 2 | 2008-01-01 |
| DR5 antibodies and uses thereof App 20070031414 - Adams; Camellia W. | 2007-02-08 |
| DR5 antibodies and uses thereof App 20060269554 - Adams; Camellia W. | 2006-11-30 |
| Apo-2 receptor App 20060251647 - Adams; Camellia W. ; et al. | 2006-11-09 |
| Antibody variants and uses thereof App 20060246004 - Adams; Camellia W. ; et al. | 2006-11-02 |
| Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies App 20060216285 - Adams; Camellia W. ; et al. | 2006-09-28 |
| Treatment with anti-ErbB2 antibodies and chemotherapeutic agents App 20060198843 - Adams; Camellia W. ; et al. | 2006-09-07 |
| Human anti-factor IX/IXa antibodies App 20060193851 - Adams; Camellia W. ; et al. | 2006-08-31 |
| Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies App 20060193854 - Adams; Camellia W. ; et al. | 2006-08-31 |
| Agonist antibodies App 20060177441 - Adams; Camellia W. ; et al. | 2006-08-10 |
| Apo-2 receptor App 20060115484 - Adams; Camellia W. ; et al. | 2006-06-01 |
| Human anti-factor IX/IXa antibodies Grant 7,049,411 - Adams , et al. May 23, 2 | 2006-05-23 |
| Human Anti-factor Ix/ixa Antibodies App 20060088534 - Adams; Camellia W. ; et al. | 2006-04-27 |
| Apo-2 receptor App 20060084147 - Adams; Camellia W. ; et al. | 2006-04-20 |
| Treatment with anti-ErbB2 antibodies and anti-hormonal compounds App 20060073143 - Adams; Camellia W. ; et al. | 2006-04-06 |
| Apo-2 receptor App 20060073570 - Adams; Camellia W. ; et al. | 2006-04-06 |
| Polypeptide variants with altered effector function App 20060067930 - Adams; Camellia W. ; et al. | 2006-03-30 |
| Apo-2 receptor App 20060035334 - Adams; Camellia W. ; et al. | 2006-02-16 |
| Immunoglobulin variants and uses thereof App 20060034835 - Adams; Camellia W. ; et al. | 2006-02-16 |
| Treatment with anti-ErbB2 antibody combinations App 20060034842 - Adams; Camellia W. ; et al. | 2006-02-16 |
| Immunoglobulin variants and uses thereof App 20060024300 - Adams; Camellia W. ; et al. | 2006-02-02 |
| Humanized anti-TGF-beta antibodies App 20050276802 - Adams, Camellia W. ; et al. | 2005-12-15 |
| Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies App 20050208043 - Adams, Camellia W. ; et al. | 2005-09-22 |
| Agonist antibodies App 20050208585 - Adams, Camellia W. ; et al. | 2005-09-22 |
| Agonist antibodies Grant 6,737,249 - Adams , et al. May 18, 2 | 2004-05-18 |
| Apo-2 receptor App 20040009552 - Adams, Camellia W. ; et al. | 2004-01-15 |
| Human anti-factor IX/IXa antibodies Grant 6,624,295 - Adams , et al. September 23, 2 | 2003-09-23 |
| Apo-2 receptor App 20030148455 - Adams, Camellia W. ; et al. | 2003-08-07 |
| Apo-2 receptor App 20020150985 - Adams, Camellia W. ; et al. | 2002-10-17 |
| Agonist antibodies Grant 6,342,220 - Adams , et al. January 29, 2 | 2002-01-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 